Successful treatment with dimethyl fumarate in a child with relapsing-remitting multiple sclerosis

Medicine and Dentistry

• Fumaric Acid Dimethyl Ester 100%
• Multiple Sclerosis 83%
• Child 66%
• Diseases 50%
• Drug 50%
• Chemotherapeutic Agent 50%
• Age 33%
• Oral Submucous Fibrosis 33%
• Recurrent Disease 16%
• Lesion 16%
• Magnetic Resonance Imaging 16%
• Disease Exacerbation 16%
• Side Effect 16%
• White Matter Lesion 16%
• Disability 16%
• Sequela 16%
• Facial Nerve Paralysis 16%
• Pediatrics Patient 16%
• Somnolence 16%
• Symptom 16%
• Unsteadiness 16%
• Common Cold Symptom 16%
• Therapeutic Procedure 16%
• Adult 16%
• Relapse 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Fumaric Acid Dimethyl Ester 100%
• Multiple Sclerosis 83%
• Diseases 50%
• Drug 50%
• Mouth Disease 33%
• Case Report 33%
• Side Effect 16%
• Prognosis 16%
• Disease Exacerbation 16%
• Recurrent Disease 16%
• Somnolence 16%
• White Matter Lesion 16%
• Disability 16%
• Symptom 16%
• Relapse 16%
• Unsteadiness 16%
• Facial Nerve Paralysis 16%
• Common Cold Symptom 16%

Neuroscience

• Multiple Sclerosis 50%
• Oral Disease 33%
• Relapsing Remitting Multiple Sclerosis 33%
• Magnetic Resonance Imaging 16%
• Somnolence 16%
• White Matter 16%
• Pediatrics 16%